Skye Bioscience
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SKYE and other ETFs, options, and stocks.About SKYE
Skye Bioscience, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new medicines that unlock the pharmaceutical potential of the endocannabinoid system to treat diseases caused by metabolic disorders, inflammation, fibrosis, and neurodegeneration. Its products include nimacimab and SBI-100 Ophthalmic Emulsion.
CEOPunit S. Dhillon
CEOPunit S. Dhillon
Employees16
Employees16
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2011
Founded2011
Employees16
Employees16
SKYE Key Statistics
Market cap58.87M
Market cap58.87M
Price-Earnings ratio-2.29
Price-Earnings ratio-2.29
Dividend yield—
Dividend yield—
Average volume222.27K
Average volume222.27K
High today$2.14
High today$2.14
Low today$1.88
Low today$1.88
Open price$2.03
Open price$2.03
Volume319.18K
Volume319.18K
52 Week high$12.45
52 Week high$12.45
52 Week low$1.14
52 Week low$1.14
Analyst ratings
100%
of 7 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own SKYE. This list is generated using Robinhood data, and it’s not a recommendation.